MEI Pharma receives over $100 million in funding commitment to launch Litecoin vault strategy

According to BlockBeats, on July 19th, Titan Partners Group and cryptocurrency investment firm GSR are jointly leading the strategic transformation of American pharmaceutical company MEI Pharma (NASDAQ: MEIP) to establish a dedicated Litecoin vault strategy. Currently, over 100 million US dollars have been committed to the project. It is worth mentioning that Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors. In addition, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy is highly aligned with the Litecoin Foundation's core mission of promoting global Litecoin adoption.